Austrian University develops code to routinely simulate bioreactors

Graz University of Technology scientist’s new software can simulate the movements of microorganisms in the reactor within hours

picture of

Breaking News

IRBM engages US oncology centre with therapeutic antibody development

The contract research organisation based in Rome has signed a service and development agreement with The University of ...

Research: Commercial cannabidiol on the UK market is illegal

Consumer products are contaminated with impurities, exceed legal limits of psychoactive cannabinoids and CBD content ...

Atelerix receives Innovate UK grant for cell therapy preservation hydrogel

The hydrogel tech increases shelf-life between 4°C and 25°C, increasing treatment flexibility as well as widening ...

What happens if a company doesn’t have any records of its R&D activities?

Companies in the UK engaged in R&D can get up to 33% of innovation expenditures back. Myriad Associates explains how to ...

CPhI MEA explores the drivers behind the multibillion-dollar market in Saudi Arabia

The Kingdom's pharmaceutical market is expected to be valued at US$10.74 billion by 2023

NGen contributes to C$4.2m Canadian viral vector manufacturing project

Canadian non-profit that matches manufacturers with new technologies will provide C$1.89m for iVexSol Canada to develop ...

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...

Novo Nordisk funds $27m global biomanufacturing programme

The five-year research and training project will be run as a collaborative effort between North Carolina State ...

Bristol-Myers Squibb invests in drug development accelerator BioMotiv

The pharmaceutical giant seeks to accelerate scientific discoveries into breakthrough therapies for patients living ...

The evolution of the pharma industry: From reactive to disruptive

Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit ...

The case for single-use architecture in pharma

Billy Sisk, Life Sciences Industry Manager, EMEA, at Rockwell Automation recently contributed to the free downloadable ...

Integrated tools for upstream process intensification: Part II

Changes to bioprocessing methodologies in the biopharmaceutical industry are being driven by the need for increased ...

Henkel extends lifespan of human skin tissue models

According to the personal care giant, the new models can be used up to 400 times longer than traditional human testing ...

Japanese collaboration pioneers NMR crystallography for drug discovery

Researchers have integrated whole structure analysis by electron diffraction and local structure analysis by solid- ...